Given the hypothesised protective role for the RA/RAR activity in the CD9, to prevent CKD and its progression, it may be desirable to prevent RA/RAR repression by albumin, aldosterone, angiotensin II, cisplatin, high glucose and LPS in these cells. The gene discussed is RARA; the disease is chronic kidney disease.